首页> 美国卫生研究院文献>PLoS Clinical Trials >Synthesis and biological evaluation of the progenitor of a new class of cephalosporin analogues, with a particular focus on structure-based computational analysis
【2h】

Synthesis and biological evaluation of the progenitor of a new class of cephalosporin analogues, with a particular focus on structure-based computational analysis

机译:新型头孢菌素类似物祖细胞的合成和生物学评估,特别是基于结构的计算分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We present the synthesis and biological evaluation of the prototype of a new class of cephalosporins, containing an additional isolated beta lactam ring with two phenyl substituents. This new compound is effective against Gram positive microorganisms, with a potency similar to that of ceftriaxone, a cephalosporin widely used in clinics and taken as a reference, and with no cytotoxicity against two different human cell lines, even at a concentration much higher than the minimal inhibitory concentration tested. Additionally, a deep computational analysis has been conducted with the aim of understanding the contribution of its moieties to the binding energy towards several penicillin-binding proteins from both Gram positive and Gram negative bacteria. All these results will help us developing derivatives of this compound with improved chemical and biological properties, such as a broader spectrum of action and/or an increased affinity towards their molecular targets.
机译:我们提出了一种新的头孢菌素原型的合成和生物学评估,该头孢菌素含有一个带有两个苯基取代基的另外的分离的β-内酰胺环。这种新化合物对革兰氏阳性微生物有效,其功效类似于头孢曲松(一种在临床上广泛使用并作为参考的头孢菌素)的功效,即使浓度远高于头孢曲松,对两种不同的人类细胞系也没有细胞毒性。测试的最小抑菌浓度。此外,已经进行了深入的计算分析,目的是了解其部分对革兰氏阳性和革兰氏阴性细菌对几种青霉素结合蛋白的结合能的贡献。所有这些结果将帮助我们开发具有改善的化学和生物学特性(例如作用范围更广和/或对其分子靶标的亲和力提高)的该化合物的衍生物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号